137 related articles for article (PubMed ID: 17512704)
41. [Treatment of acute exacerbations of chronic bronchitis. Multicenter, randomized comparative study of cefuroxime axetil versus ofloxacin].
Kleckow M
Fortschr Med; 1991 Jul; 109(22):450-4. PubMed ID: 1937326
[TBL] [Abstract][Full Text] [Related]
42. A randomized, double-blind study comparing 5 days oral gemifloxacin with 7 days oral levofloxacin in patients with acute exacerbation of chronic bronchitis.
Sethi S; Fogarty C; Fulambarker A
Respir Med; 2004 Aug; 98(8):697-707. PubMed ID: 15303633
[TBL] [Abstract][Full Text] [Related]
43. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
44. Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil.
Alvarez-Sala JL; Kardos P; Martínez-Beltrán J; Coronel P; Aguilar L
Antimicrob Agents Chemother; 2006 May; 50(5):1762-7. PubMed ID: 16641447
[TBL] [Abstract][Full Text] [Related]
45. [Infectious exacerbation of chronic obstructive pulmonary disease: prospects for high-dose levofloxacin therapy].
Astaf'ev AV; Styrt EA; Sinopal'nikov AI
Klin Med (Mosk); 2013; 91(3):44-50. PubMed ID: 23789452
[TBL] [Abstract][Full Text] [Related]
46. Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial.
Nouira S; Marghli S; Belghith M; Besbes L; Elatrous S; Abroug F
Lancet; 2001 Dec; 358(9298):2020-5. PubMed ID: 11755608
[TBL] [Abstract][Full Text] [Related]
47. Wobenzym in treatment of recurrent obstructive bronchitis in children.
Lanchava N; Nemsadze K; Chkhaidze I; Kandelaki E; Nareklishvili N
Georgian Med News; 2005 Oct; (127):50-3. PubMed ID: 16308444
[TBL] [Abstract][Full Text] [Related]
48. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons
J Cataract Refract Surg; 2007 Jun; 33(6):978-88. PubMed ID: 17531690
[TBL] [Abstract][Full Text] [Related]
49. Is co-morbidity taken into account in the antibiotic management of elderly patients with acute bronchitis and COPD exacerbations?
Bont J; Hak E; Birkhoff CE; Hoes AW; Verheij TJ
Fam Pract; 2007 Sep; 24(4):317-22. PubMed ID: 17602175
[TBL] [Abstract][Full Text] [Related]
50. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
51. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
Balkissoon R; Make B
COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
[TBL] [Abstract][Full Text] [Related]
52. Open study on efficacy and safety of levofloxacin in treatment of uncomplicated typhoid fever.
Nelwan RH; Chen K; Nafrialdi ; Paramita D
Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):126-30. PubMed ID: 16771224
[TBL] [Abstract][Full Text] [Related]
53. Oral bacterial vaccines for the prevention of acute exacerbations in chronic obstructive pulmonary disease and chronic bronchitis.
Arandjus C; Black PN; Poole PJ; Wood Baker R; Steurer-Stey C
Respir Med; 2006 Oct; 100(10):1671-81. PubMed ID: 16934969
[TBL] [Abstract][Full Text] [Related]
54. Levofloxacin in enteric fever--a study.
Kadam GS; Naikwadi A; Rao SK; Sawardekar SS; Gawde A; Baliga V; Desai A
J Indian Med Assoc; 2005 Aug; 103(8):441-2, 446. PubMed ID: 16363202
[TBL] [Abstract][Full Text] [Related]
55. International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis.
Van Herwaarden CL; Langan CE; Siemon G; Rudolph C; Keyserling CH; Nemeth MA; Tack KJ
Int J Infect Dis; 2000; 4(1):26-33. PubMed ID: 10689211
[TBL] [Abstract][Full Text] [Related]
56. Sequential therapy with cefuroxime followed by cefuroxime axetil in acute exacerbations of chronic bronchitis.
Vogel F; Droszcz W; Vondra V; Reisenberg K; Marr C; Staley H
J Antimicrob Chemother; 1997 Dec; 40(6):863-71. PubMed ID: 9462439
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
58. Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin.
Viale P; Furlanut M; Scudeller L; Pavan F; Negri C; Crapis M; Zamparini E; Zuiani C; Cristini F; Pea F
Int J Antimicrob Agents; 2009 Apr; 33(4):379-82. PubMed ID: 19097864
[TBL] [Abstract][Full Text] [Related]
59. Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease.
Bhatt SP; Khandelwal P; Nanda S; Stoltzfus JC; Fioravanti GT
Respir Med; 2008 Jul; 102(7):999-1003. PubMed ID: 18396393
[TBL] [Abstract][Full Text] [Related]
60. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
